a.kowalczyk
TL2 Regular · Kraków, PL
Reads carefully, cites properly, posts rarely.
Joined 22 October 2024 · last posted 4d
80 posts, newest first. Showing up to 150.
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #64 · Access › Insurance & coverage · 24 Jul 2026 · 0 likes A clinician's supporting letter that addresses the criteria explicitly is worth considerably more than one that describes the patient generally.
-
Revisiting: Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #11 · Compounds › Retatrutide · 23 Jul 2026 · 26 likes Taking post #10 at face value and following it one step further. Triple agonism at GLP-1, GIP and glucagon receptors is the defining feature and the glucagon limb is…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #104 · Analytics › Home & field testing · 20 Jul 2026 · 12 likes Worth separating two things that post #102 runs together. Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #103 · Sourcing › Independent verification · 18 Jul 2026 · 11 likes Coming back to post #99, because the follow-up matters more than the original answer. Asking the supplier before publishing a discrepancy is the convention here. Most…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #71 · Evidence › Journal club · 16 Jul 2026 · 11 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions. On reflection I…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #119 · Evidence › Journal club · 16 Jul 2026 · 2 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later.
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #121 · Start Here › How to Ask · 12 Jul 2026 · 20 likes It is fine to say you cannot explain why you are asking. Nobody will press, and the technical part of the question can usually be answered without the context. A…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #86 · Analytics › Method validation · 11 Jul 2026 · 0 likes Specificity is the first question: does the method separate the analyte from everything reasonably expected to be present? A method that has not been challenged with…
-
Common supplements people ask about, assessed one at a time Replied, post #24 · Practice › Interactions · 9 Jul 2026 · 17 likes Confirming post #23 from a second method, which matters more than confirming it from a second person. Common supplements: I would want to see the raw numbers rather…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #76 · Analytics › Home & field testing · 1 Jul 2026 · 7 likes This follows post #74 rather than contradicting it. Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick…
-
Aggregate verification data across the directory, with caveats Replied, post #22 · Sourcing › Independent verification · 1 Jul 2026 · 4 likes Verification records are dated because they expire in usefulness. A result from two years ago describes a lot from two years ago. Take the reasoning and check the…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #6 · Compounds › Secretagogues & GH axis · 23 Jun 2026 · 0 likes Adding a data point of agreement rather than a data point.
-
The anatomy of a question that gets answered within an hour Replied, post #87 · Start Here › How to Ask · 23 Jun 2026 · 1 like A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
-
Alcohol: what is documented and what is folklore Replied, post #62 · Practice › Interactions · 17 Jun 2026 · 22 likes Whatever the answer on alcohol turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
-
Does a peptide degrade silently, with no visual change? Replied, post #34 · Practice › Storage & stability · 25 May 2026 · 0 likes On post #30 — agreed on the reasoning, with one qualification. The reason peptide is hard to answer is that the obvious measurement and the relevant quantity are not…
-
Alcohol: what is documented and what is folklore Replied, post #9 · Practice › Interactions · 11 May 2026 · 4 likes Post #8 is right about the mechanism and I think understates the practical bit. Adding what did not work for me on alcohol, since the failures never get written up and…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #24 · Clinical › Comorbidities · 5 May 2026 · 0 likes The strongest argument against my own position on PCOS and metabolic overlap, stated as well as I can state it, since nobody else has yet.
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #120 · Analytics › Mass spectrometry · 27 Apr 2026 · 29 likes Post #116 put the caveat in the right place and I want to underline it. The honest summary of what a mass result buys you: it narrows the field of what the material…
-
Insomnia at a dose step: reported experiences — the long version Replied, post #14 · Wellbeing › Sleep · 22 Apr 2026 · 5 likes Vivid dreams are reported here and are not well characterised in the published literature for this class.
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #71 · Practice › Reconstitution · 22 Apr 2026 · 0 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #104 · Analytics › Mass spectrometry · 11 Apr 2026 · 0 likes Resolution and mass accuracy are different specifications. An instrument can resolve two species and still assign their masses imprecisely, and the reverse is also…
-
Spike-and-recover accuracy for a peptide assay Replied, post #92 · Analytics › Method validation · 10 Apr 2026 · 0 likes I keep a log for spike-and-recover accuracy specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #37 · Sourcing › Independent verification · 7 Apr 2026 · 26 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which.
-
Type 2 diabetes and the largest part of the evidence base Replied, post #39 · Clinical › Comorbidities · 22 Mar 2026 · 0 likes Answering the question post #35 raises rather than the one it answers. Where somebody is on several medicines, the interaction question and the comorbidity question are…
-
Reading an interaction checker output critically Replied, post #153 · Practice › Interactions · 22 Mar 2026 · 11 likes Worth stating the null on reading an interaction checker output before we explain it: the observation may be nothing. That possibility deserves a sentence and usually…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #14 · Clinical › Bloodwork · 13 Mar 2026 · 2 likes Post #12 describes the usual case. This is about the unusual one. Two questions I would want answered before drawing anything from the Thyroid function tests during…
-
A site rotation scheme that is easy enough to actually follow Replied, post #16 · Practice › Administration · 8 Mar 2026 · 6 likes Taking post #14 at face value and following it one step further. If you have to inject at a different time of day than usual, that is a much smaller perturbation than…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #5 · marked as the solution · Practice › Interactions · 2 Mar 2026 · 9 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. Widely repeated interaction claim would be much easier to settle if anyone…
-
Five questions in one post gets you one answer — how to split them Replied, post #21 · Start Here › How to Ask · 28 Feb 2026 · 0 likes Timeline questions need the timeline. Dates, in order, with what happened on each. "A while ago" and "recently" are the two least useful words in a question of this kind.
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #23 · Analytics › Impurities & related substances · 23 Feb 2026 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #79 · Documentation › Wiki requests · 9 Feb 2026 · 22 likes Narrowing post #76, because the general version has more than one answer. Accessibility feedback: if you have trouble accessing or reading a maintained page (screen…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #109 · Sourcing › Independent verification · 5 Feb 2026 · 3 likes Confirming post #108 from a second method, which matters more than confirming it from a second person. Requesting the batch record rather than the certificate is a…
-
Whether protein timing matters at a large deficit Replied, post #20 · Nutrition & Training › Protein & intake · 27 Jan 2026 · 19 likes Adding the measurement that post #17 says would settle it. Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain lean…
-
Coming back to: Training through a dose escalation week Replied, post #4 · Nutrition & Training › Resistance training · 6 Jan 2026 · 0 likes Where I part company with the opening post, and it is a narrow parting. Training fasted or fed is a comfort question at these intakes rather than a performance question…
-
Search filters: what is missing Replied, post #15 · Meta › Site feedback · 4 Jan 2026 · 0 likes Taking post #12 at face value and following it one step further. Last piece of feedback: the site is much better on a narrow screen than it was six months ago and…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #75 · Practice › Side effects · 29 Dec 2025 · 3 likes This is the answer, and the reason it is the answer is the more useful part.
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #83 · Analytics › Home & field testing · 20 Dec 2025 · 12 likes Building on post #82 rather than restating it. The number people quote for home kit substitute is a central estimate presented without its interval, and the interval is…
-
Comparing two chromatograms from different laboratories, properly Replied, post #39 · Analytics › HPLC & UHPLC · 9 Dec 2025 · 1 like Where I part company with post #35, and it is a narrow parting. Detection at 214 nanometres sees the peptide bond and therefore sees almost everything peptidic. At 280…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #7 · Compounds › Tirzepatide · 30 Nov 2025 · 0 likes Picking up post #6: that is the part I would want checked first. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #2 · Sourcing › Logistics · 27 Nov 2025 · 0 likes Everything in the opening post holds. The case it does not cover is the one I have. Anyone deciding whether a delay is a problem should ask what would change if they…
-
Second pass at: Programming during a large energy deficit Replied, post #99 · Nutrition & Training › Resistance training · 27 Nov 2025 · 1 like On post #95 — agreed on the reasoning, with one qualification. Where training is new, the early gains are largely neural, which is why they can appear even during a…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #23 · Compounds › Other compounds · 23 Nov 2025 · 11 likes Adding the measurement that post #20 says would settle it. Solubility varies far more across this subcategory than within the incretins. A compound that needs a…
-
Robustness: the parameters worth deliberately varying Replied, post #9 · Analytics › Method validation · 19 Nov 2025 · 0 likes I would call the community position on robustness likely rather than established, and I would be comfortable defending that hedge.
-
MHRA statements, read directly Replied, post #30 · Regional › UK & Ireland · 12 Nov 2025 · 2 likes Building on post #29 rather than restating it. Where guidance distinguishes between indications, quoting the indication is essential. The same compound has different…
-
[2026 update] What steady state means for the decision to escalate Replied, post #31 · Practice › Dosing & titration · 8 Nov 2025 · 0 likes Since steady state keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #19 · Compounds › Oral incretins · 27 Oct 2025 · 0 likes Confirming post #17 from a second method, which matters more than confirming it from a second person. Trial adherence in an oral trial with strict administration…
-
Compounds this community declines to help with, and why Replied, post #79 · Compounds › Other compounds · 7 Oct 2025 · 4 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #36 · Compounds › Cagrilintide & amylin analogues · 2 Oct 2025 · 16 likes Post #32 put the caveat in the right place and I want to underline it. On storage: aggregation-prone peptides are the ones where repeated warming and cooling does the…
-
Why the timeline is on the right and not the left Replied, post #69 · Meta › Site feedback · 16 Sep 2025 · 10 likes I think the timeline question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #2 · Evidence › Study critique · 11 Sep 2025 · 18 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Pinch or no pinch, and how needle length changes the answer Replied, post #35 · Practice › Administration · 27 Aug 2025 · 0 likes Pinch is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
A request that was declined, and the reasoning — a second dataset Replied, post #22 · Documentation › Wiki requests · 7 Aug 2025 · 8 likes Confirming post #21 from a second method, which matters more than confirming it from a second person. Say what would make the page wrong. A page whose failure…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #48 · Clinical › Special populations · 27 Jul 2025 · 1 like What I can speak to on History of disordered eating is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
Request: a diff view for wiki revisions — the long version Replied, post #19 · Meta › Feature requests · 15 Jul 2025 · 17 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Counter-ion content and its effect on measured mass Replied, post #83 · Analytics › Mass spectrometry · 5 Jul 2025 · 0 likes Confirming post #82 from a second method, which matters more than confirming it from a second person. The honest summary of what a mass result buys you: it narrows the…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #69 · Compounds › Retatrutide · 23 Jun 2025 · 29 likes The honest answer on Triple agonism is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter. Most…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #36 · Practice › Dosing & titration · 22 Jun 2025 · 4 likes The confident answers on Escalating every six weeks instead and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #11 · Compounds › Oral incretins · 10 Jun 2025 · 3 likes Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a peptide across the gastric epithelium at usable…
-
A report I filed that turned out to be wrong, and the correction Replied, post #90 · Sourcing › Vendor reports · 7 Jun 2025 · 1 like Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Tracking that stops updating and then resumes Started this topic · Sourcing › Logistics · 27 May 2025 · 8 likes On the subject in the title: Tracking that stops updating and then resumes Working notes rather than a conclusion. A logistics question, since the answers here are…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #76 · Practice › Reconstitution · 23 May 2025 · 2 likes Post #74 answers the question as asked. The question underneath it is different. Write the reconstitution date and the concentration on the vial. Not on a note, on the…
-
Preparing for an appointment: one page, three questions Replied, post #18 · Clinical › Prescriber conversations · 11 May 2025 · 0 likes Building on post #16 rather than restating it. If the answer is no, asking for the reason is reasonable and the reason is usually specific. It is also what makes an…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #18 · Sourcing › Independent verification · 27 Apr 2025 · 13 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Carryover and the ghost peak from last week's standard Replied, post #18 · Analytics › HPLC & UHPLC · 3 Apr 2025 · 0 likes Post #16 is the version of this I will quote in future. One addition. Before the thread moves on from carryover — what is the sample size behind the claim? I am not…
-
Retatrutide dose escalation in the published trials Replied, post #68 · Compounds › Retatrutide · 30 Mar 2025 · 33 likes Dose-response in the phase 2 obesity work was clear across the studied range, with no obvious plateau within it. Extrapolating beyond the highest studied dose from that…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #112 · Compounds › Semaglutide · 22 Mar 2025 · 0 likes Distinguishing three things in the published dose-response for semaglutide discussion that keep getting used interchangeably: the observation, the proposed mechanism,…
-
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #2 · Devices › Pens & autoinjectors · 15 Feb 2025 · 19 likes Worth separating two things that the opening post runs together. Nothing here is medical advice, and pen technique is the single easiest thing to have demonstrated in…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #59 · Compounds › Semaglutide · 11 Feb 2025 · 6 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #25 · Analytics › COA interpretation · 19 Jan 2025 · 7 likes Worth separating two things that post #23 runs together. An itemised related-substances table with retention times says considerably more about the synthesis than a…
-
Follow-up: Individual participant data versus aggregate data Replied, post #27 · Evidence › Meta-analyses · 8 Jan 2025 · 11 likes Where I part company with post #23, and it is a narrow parting. Two questions I would want answered before drawing anything from the Individual participant data versus…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #22 · Analytics › Mass spectrometry · 8 Jan 2025 · 21 likes Resolution and mass accuracy are different specifications. An instrument can resolve two species and still assign their masses imprecisely, and the reverse is also…
-
When "no data" is the complete and final answer Replied, post #53 · Compounds › Other compounds · 29 Dec 2024 · 0 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #103 · Compounds › Oral incretins · 28 Dec 2024 · 0 likes Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a peptide across the gastric epithelium at usable…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #75 · Clinical › Prescriber conversations · 18 Nov 2024 · 20 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #86 · Sourcing › Independent verification · 26 Sep 2024 · 5 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Irish differences from the UK position Replied, post #6 · Regional › UK & Ireland · 23 Sep 2024 · 0 likes Importing for personal use: importing a prescription-only medicine without a prescription is not lawful. Material sold as research-use-only is not a licensed medicine…
-
When to suspect the method rather than the sample Replied, post #11 · Analytics › Method validation · 11 Sep 2024 · 0 likes Where I part company with post #9, and it is a narrow parting. Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance.…
-
Cold packs, phase-change material, and what survives ten days Replied, post #99 · Sourcing › Logistics · 13 Jul 2024 · 7 likes Answering the cold packs question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first…
-
Promotion criteria, and the one that stops most nominations Replied, post #11 · Documentation › Doc review · 2 Jul 2024 · 24 likes Post #8 answers the question as asked. The question underneath it is different. Second maintainers matter. A single maintainer is a single point of failure and every…
-
Two sessions a week versus four: what the evidence supports — a second dataset Replied, post #21 · Nutrition & Training › Resistance training · 30 Jun 2024 · 22 likes Frequency matters less than consistency and progression. Two sessions a week done every week beats four sessions done occasionally. Flagging that the sources on this…